BiopharmIQ
Catalyst Calendar
Big Movers™
All Big Movers™
Current Qtr Report
PDUFA Events
PDUFA Calendar
Current PDUFA Report
Company Screener
M&A Activity
Historical M&A Data
M&A Target Ideas
Meeting Calendar
Hedge Funds
Analysts & Portfolios

My WatchlistsMy Notes
Try Pro FreeAlready have an account? Login

Enterprise Value

1.434B

Cash

110.8M

Avg Qtr Burn

-24.5M

Short % of Float

9.30%

Insider Ownership

46.08%

Institutional Own.

24.25%

Qtr Updated

03/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
Rayaldee (calcifediol ER capsules) Details
CKD (Chronic kidney disease)

Approved

Quarterly sales

Some catalyst date

You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
NGENLA® Somatrogon Details
Pediatric growth hormone deficiency

NDA

FDA meeting

Some catalyst date

You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
OPK88003 (oxyntomodulin analog) (FLP-1 agonist) Details
Type 2 diabetes

Phase 2

Update

Some catalyst date

You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Rayaldee Details
COVID-19

Phase 2

Update

Some catalyst date

You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.